First-in-man clinical trial of the oral pan-AKT inhibitor MK-206 in patients with advanced solid tumors

Timothy A. Yap, Li Yan, Amita Patnaik, Ivy Fearen, David Olmos, Kyriakos Papadopoulos, Richard D. Baird, Liliana Delgado, Adekemi Taylor, Lisa Lupinacci, Ruth Riisnaes, Lorna L. Pope, Simon P. Heaton, George Thomas, Michelle D. Garrett, Daniel M. Sullivan, Johann S. De Bono, Anthony W. Tolcher

Research output: Contribution to journal › Article › peer-review